Skip to Main Content

Author Details

Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
2003
176
61
PMIDPaper TitleJournal TitlePublished Year
36354753Molecular Monitoring in Endometrial Cancer-Ready for Prime Time?Clin Cancer Res2023
36354753Molecular Monitoring in Endometrial Cancer-Ready for Prime Time?Clin Cancer Res2023
37572657A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trials.Med2023
37632107Characterizing Risk Factors for Hospitalization and Clinical Characteristics in a Cohort of COVID-19 Patients Enrolled in the GENCOV Study.Viruses2023
36969007Genetic analyses of DNA repair pathway associated genes implicate new candidate cancer predisposing genes in ancestrally defined ovarian cancer cases.Front Oncol2023
36833203Molecular Genetic Characteristics of <i>FANCI</i>, a Proposed New Ovarian Cancer Predisposing Gene.Genes (Basel)2023
36585784Evaluation of single-cell RNAseq labelling algorithms using cancer datasets.Brief Bioinform2023
37402621MEDIPIPE: an automated and comprehensive pipeline for cfMeDIP-seq data quality control and analysis.Bioinformatics2023
36821580Defining and targeting tumor-associated macrophages in malignant mesothelioma.Proc Natl Acad Sci U S A2023
36639200Single-cell profiling of multiple myeloma reveals molecular response to FGFR3 inhibitor despite clinical progression.Cold Spring Harb Mol Case Stud2023
37202533Identification of acquired Notch3 dependency in metastatic Head and Neck Cancer.Commun Biol2023
37327320Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression.Clin Cancer Res2023
37004911Distinguishing Gastric/Esophageal Adenocarcinoma from Pancreatic Adenocarcinoma Using Methylation-Based Droplet Digital PCR.Lab Invest2023
36943460Identification of antigenic epitopes recognized by tumor infiltrating lymphocytes in high grade serous ovarian cancer by multi-omics profiling of the auto-antigen repertoire.Cancer Immunol Immunother2023
37126021Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency.Clin Cancer Res2023
36747619Germline pathogenic variants in 786 neuroblastoma patients.medRxiv2023
37377903Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni Syndrome.Cancer Res Commun2023
36860651Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma.Cancer Res Commun2023
37164978Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.Nat Commun2023
37038005Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab.Nat Cancer2023
37481477Germline whole genome sequencing in adults with multiple primary tumors.Fam Cancer2023
37632107Characterizing Risk Factors for Hospitalization and Clinical Characteristics in a Cohort of COVID-19 Patients Enrolled in the GENCOV Study.Viruses2023
37481477Germline whole genome sequencing in adults with multiple primary tumors.Fam Cancer2023
37572657A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trials.Med2023
37126021Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency.Clin Cancer Res2023
36943460Identification of antigenic epitopes recognized by tumor infiltrating lymphocytes in high grade serous ovarian cancer by multi-omics profiling of the auto-antigen repertoire.Cancer Immunol Immunother2023
37377903Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni Syndrome.Cancer Res Commun2023
37038005Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab.Nat Cancer2023
37402621MEDIPIPE: an automated and comprehensive pipeline for cfMeDIP-seq data quality control and analysis.Bioinformatics2023
37004911Distinguishing Gastric/Esophageal Adenocarcinoma from Pancreatic Adenocarcinoma Using Methylation-Based Droplet Digital PCR.Lab Invest2023
37202533Identification of acquired Notch3 dependency in metastatic Head and Neck Cancer.Commun Biol2023
36969007Genetic analyses of DNA repair pathway associated genes implicate new candidate cancer predisposing genes in ancestrally defined ovarian cancer cases.Front Oncol2023
37164978Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.Nat Commun2023
37327320Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression.Clin Cancer Res2023
36585784Evaluation of single-cell RNAseq labelling algorithms using cancer datasets.Brief Bioinform2023
36747619Germline pathogenic variants in 786 neuroblastoma patients.medRxiv2023
36833203Molecular Genetic Characteristics of <i>FANCI</i>, a Proposed New Ovarian Cancer Predisposing Gene.Genes (Basel)2023
36639200Single-cell profiling of multiple myeloma reveals molecular response to FGFR3 inhibitor despite clinical progression.Cold Spring Harb Mol Case Stud2023
36860651Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma.Cancer Res Commun2023
36821580Defining and targeting tumor-associated macrophages in malignant mesothelioma.Proc Natl Acad Sci U S A2023
34556523Mutations in Noncoding <i>Cis</i>-Regulatory Elements Reveal Cancer Driver Cistromes in Luminal Breast Cancer.Mol Cancer Res2022
36309516The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors.Nat Commun2022
35835962Pre-encoded responsiveness to type I interferon in the peripheral immune system defines outcome of PD1 blockade therapy.Nat Immunol2022
35652221REFLECTions on Combination Therapies Empowered by Data Sharing.Cancer Discov2022
36170831Characterization of the minimal residual disease state reveals distinct evolutionary trajectories of human glioblastoma.Cell Rep2022
35896551Author Correction: Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-κB activation and immune escape.Nat Commun2022
35385106"Game Changer": Health Professionals' Views on the Clinical Utility of Circulating Tumor DNA Testing in Hereditary Cancer Syndrome Management.Oncologist2022
36087071Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphoma.Am J Hematol2022
35379580All is not lost: learning from 9p21 loss in cancer.Trends Immunol2022
36131014Failure of human rhombic lip differentiation underlies medulloblastoma formation.Nature2022
  • 1 - 50 of 352

Recommended Authors

Sebastian Uhrig
National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)
Career Start Year 2016
Number of shared co-authors 16
Daniel H Hovelson
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2014
Number of shared co-authors 5
Aparna Pallavajjala
Johns Hopkins University School of Medicine
Career Start Year 2014
Number of shared co-authors 1
Daniel Vod??k
Institute for Cancer Research, Oslo University Hospital
Career Start Year 2014
Number of shared co-authors 22
Arshi Arora
Memorial Sloan Kettering Cancer Center
Career Start Year 2011
Number of shared co-authors 3
Dan R Robinson
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2011
Number of shared co-authors 17
Gunes Gundem
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 19
Emilie Lalonde
University of Pennsylvania
Career Start Year 2010
Number of shared co-authors 38
Joshua F McMichael
Washington University
Career Start Year 2009
Number of shared co-authors 26
Eliezer M Van Allen
Dana-Farber Cancer Institute
Career Start Year 2009
Number of shared co-authors 77
Sabah Kadri
Abbvie Inc., Genomics Research Center
Career Start Year 2009
Number of shared co-authors 4
Ignaty Leshchiner
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year 2008
Number of shared co-authors 30
Oscar Krijgsman
The Netherlands Cancer Institute
Career Start Year 2008
Number of shared co-authors 8
Ken Chen
University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 39
David C Wedge
Manchester Cancer Research Centre, University of Manchester
Career Start Year 2006
Number of shared co-authors 36
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 37
Barry S Taylor
Memorial Sloan Kettering Cancer Center
Career Start Year 2006
Number of shared co-authors 52
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 3
Peter Van Loo
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 36
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 9
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 56
Michael D McLellan
McDonnell Genome Institute, Washington University in St. Louis
Career Start Year 2003
Number of shared co-authors 30
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 46
Volker Endris
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2001
Number of shared co-authors 13
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 9
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Career Start Year 1999
Number of shared co-authors 31
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 58
John V Pearson
QIMR Berghofer Medical Research Institute
Career Start Year 1996
Number of shared co-authors 37
Adam Butler
Wellcome Sanger Institute
Career Start Year 1996
Number of shared co-authors 44
Elaine R Mardis
The Ohio State University
Career Start Year 1988
Number of shared co-authors 75

Collaborators

Jeff P Bruce
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 26
Matthew Meyerson
Broad Institute
Co-authored papers 19
Michael D Taylor
The Hospital for Sick Children
Co-authored papers 19
Marco A Marra
University of British Columbia
Co-authored papers 19
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 19
Peter B Dirks
The Hospital for Sick Children, University of Toronto
Co-authored papers 15
Lillian L Siu
Princess Margaret Cancer Centre, University Ave
Co-authored papers 13
Michael S Lawrence
Co-authored papers 13
Uri Tabori
Co-authored papers 12
Benjamin Haibe-Kains
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 12
Blaise A Clarke
University of Toronto.
Co-authored papers 12
Philippe L Bedard
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 12
Stacey Gabriel
Broad Institute of MIT and Harvard
Co-authored papers 11
Gelareh Zadeh
University of Toronto
Co-authored papers 11
Richard A Moore
Co-authored papers 11
Kristian Cibulskis
Co-authored papers 11
Kenneth Aldape
National Cancer Institute
Co-authored papers 11
Cynthia Hawkins
The Hospital for Sick Children
Co-authored papers 10
David Malkin
Hospital for Sick Children
Co-authored papers 10
Andrey Sivachenko
Cystic Fibrosis Foundation
Co-authored papers 10
Steven J M Jones
University of British Columbia
Co-authored papers 10
Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 10
Alex H Ramos
Co-authored papers 9
Mathieu Lupien
Princess Margaret Cancer Research Centre
Co-authored papers 9
Daniel Auclair
Co-authored papers 9
Eric S Lander
Vanderbilt-Ingram Cancer Center, Vanderbilt University
Co-authored papers 9
Scott L Carter
Co-authored papers 8
Vijay Ramaswamy
Hospital for Sick Children
Co-authored papers 8
Florence M G Cavalli
Institut Curie, PSL Research University
Co-authored papers 8
Marc Remke
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers 8
Release 1.2